The risk of developing type 2 diabetes was as much as 24% lower among people with a diet rich in selenium….
Read More »Diabetes In Control
Exercise and Sport in Diabetes, 2nd Ed, Part 7: Adjusting Insulin Dosing for Physical Activity
2.9 Insulin Dose Adjustment The following is an excerpt that answers questions regarding the insulin dosing for exercise.
Read More »Editor’s Desk: Left Knees, Right Knees, Who Has Diabetes?
Your response to the Homerun Slides on the Position Statement of the ADA and the EASD on the Management of Type 2 Diabetes has been overwhelming. I have received a lot of emails hailing the fact that this is the first time these guidelines have been individualized based on real …
Read More »ADA-EASD Position Statement: Management of Hyperglycemia in T2DM, Part 4 of 4
This week’s set of Homerun Slides wraps up our series on the new ADA-EASD Position Statement: Management of Hyperglycemia in T2DM. "Other Considerations" topics covered include Renal Disease, Liver Dysfunction and Hypoglycemia, and Guidelines for Glycemia, BP, & Lipid Control are also provided….
Read More »An Educator’s Perspective: Janet Carson, R.N., C.D.E., Largo, FL
Often times there can be difficulty getting approval for the patient to use a GLP-1 analog and so the patient may miss a few days of the medication and possibly decide they don’t want to continue. I have gotten in the habit of ordering the medication from the pharmacy the …
Read More »An Endocrinologist’s Perspective: Dr. Falal Taris, MD, Diabetes, Metabolism & Endocrinology, Internal Medicine
I have been using GLP-1 analogs with my patients for the past five years and have seen many patients find reasons to stop using the medication. They complain about nausea, they complain about the cost, they say the needle hurts and they have even told me that they can’t get …
Read More »A Primary Care Physician’s Perspective: Dr. Norris Brown, Austin, TX
When the GLP-1 analogs first came out I was slow to start using them. As a primary care physician in a busy multi-practitioner office I was used to working with oral medications for diabetes, and only as a last resort would I put patients on basal insulin. If my patients …
Read More »SGLT Inhibitors
History of the sodium-glucose co-transporter (SGLT) inhibitors by Erica Paul, PharmD, Graduate Intern University of Florida College of Pharmacy Back in the late 1800’s, a compound called phlorizin, found in the bark of apple trees, was isolated by French chemists. Since then it has been put to use in multiple …
Read More »San MediTech’s Dynamic Continuous Glucose Monitoring System
San MediTech’s Dynamic Continuous Glucose Monitoring System San MediTech’s Dynamic CGMS was introduced, developed and has been approved in China. The new CGMS system was on display at the 72nd ADA Scientific Sessions Exhibit Hall. It has not been approved for use in the U.S.
Read More »Editor’s Desk: Keeping Your Patients on Track with GLP-1 Therapy
Most clinicians I work with or have chatted with want to get their patients in optimal control of their glucose levels. We all work hard to find that right combination of medication, food choices, and physical activity that will achieve our patients’ goals. This means that we ask patients to …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.